Breast Cancer Clinical Trial
Official title:
Feasibility and Impact of Yoga, Self-hypnosis and Cognitive-behavioral Group Interventions in Improving Well-being of Breast Cancer Patients
This is a clinical non-randomized prospective study. This study had two objectives. The fist one was to determine the interest of breast cancer patients in participating in one of three group interventions (CBT, yoga or self-hypnosis) by assessing the participation rate, the reasons for choosing a particular group or decline the offer. The second objective was to evaluate and compare the benefits of these three interventions on emotional distress, QoL, sleep quality and mental adjustment to cancer, at three times after the end of the interventions (just after the end, at a 3-month and at a 9-month follow-up).
This study had two objectives. The fist one was to determine the interest of breast cancer
patients in participating in one of three group interventions (cognitive-behavioral therapy,
yoga or self-hypnosis) by assessing the participation rate, the reasons for choosing a
particular group or decline the offer. The second objective was to evaluate and compare the
benefits of these three interventions on emotional distress, QoL, sleep quality and mental
adjustment to cancer.
Eligible breast cancer patients were identified through an institutional database or by
referring physicians and were approached by phone to inform them of the intervention. They
were given a choice between the three group interventions: CBT, yoga and self-hypnosis.
Patients who agreed not to participate in any of the interventions were included in the
control group. After giving written informed consent, patients completed a baseline
assessment including self-reported measures. Follow-up assessment was conducted one week
after the group intervention, and at a 3-month and 9-month follow-up. Interventions were
proposed according to previous results showing the patient's interest in CBT, yoga and
self-hypnosis, and the expertise of the team. Each intervention included 6 sessions of 1.5
hours.
The primary outcome measure was the interest in the three interventions (participation rate
in each group). Since the study was first designed to determine interest, no sample size
calculation was performed. Secondary outcomes were responses concerning emotional distress,
QoL, sleep quality and mental adjustment to cancer assessed with self-reported questionnaires
before and after the group interventions.
Descriptive statistics (percentages, means and standard deviation (SD)) were used to describe
the proportions of patients who were interested in the group interventions and to examine
their demographic, medical and psychological data. Baseline time 0 demographic, medical and
psychological data were compared between groups to test for initial group equivalency using
inferential statistics: analysis of variance (ANOVA) and Chi-square test, as appropriate. To
be considered for the data analysis, patients had to attend at least three sessions.
Multivariate analyses were calculated regarding group interventions and time of medical
treatments (during or after chemo/radiation therapy). The pre- and post-assessment comparison
of each measure within each group was made using the Wilcoxon test for matched pairs. All
statistical tests were two-tailed, and a P-value <0.05 was considered statistically
significant. Investigators also calculated Cohen's d effect size for each group. The analyses
were performed with SPSS Version 21.0 (IBM Corp., Armonk, N.Y).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |